Ablynx NV
DelistedCIK 1617582fmd_1Y1E99A2XGTQC7ZRZG9EG8PGXZManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2015 to Dec 31, 2017, 3 periods
Latest annual · FY2017
Millions- Total revenues
- 56
- Operating income
- (54)
- Net income
- (109)
- Free cash flow
- (60)
Ablynx NV financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Revenue | €55.5 million | €85.2 million | -34.8% | 20-F/A 2018-04-05 · proof |
| Operating income | -€54.2 million | -€28.6 million | 20-F/A 2018-04-05 · proof | |
| Net income | -€108.5 million | -€1.1 million | 20-F/A 2018-04-05 · proof | |
| Cash from operating activities | -€57.8 million | -€66.6 million | 20-F/A 2018-04-05 · proof | |
| Free cash flow | -€60.2 million | -€69.5 million | 20-F/A 2018-04-05 · proof | |
| Total assets | €389.8 million | €266.8 million | +46.1% | 20-F/A 2018-04-05 · proof |
| Total liabilities | €210 million | €163.7 million | +28.3% | 20-F/A 2018-04-05 · proof |
| Cash and cash equivalents | €15 million | €53.4 million | -72% | 20-F/A 2018-04-05 · proof |
- What was Ablynx NV's revenue in fiscal 2017?
- Ablynx NV reported revenue of €55.5 million for fiscal 2017 (the year ended Dec 31, 2017), against €85.2 million the year before (-34.8%). Source: the 20-F/A filed with the SEC on Apr 5, 2018. SEC
- What was Ablynx NV's operating income in fiscal 2017?
- Ablynx NV reported operating income of -€54.2 million for fiscal 2017 (the year ended Dec 31, 2017), against -€28.6 million the year before. Source: the 20-F/A filed with the SEC on Apr 5, 2018. SEC
- What was Ablynx NV's net income in fiscal 2017?
- Ablynx NV reported net income of -€108.5 million for fiscal 2017 (the year ended Dec 31, 2017), against -€1.1 million the year before. Source: the 20-F/A filed with the SEC on Apr 5, 2018. SEC
- What was Ablynx NV's cash from operating activities in fiscal 2017?
- Ablynx NV reported cash from operating activities of -€57.8 million for fiscal 2017 (the year ended Dec 31, 2017), against -€66.6 million the year before. Source: the 20-F/A filed with the SEC on Apr 5, 2018. SEC
- What was Ablynx NV's free cash flow in fiscal 2017?
- Ablynx NV reported free cash flow of -€60.2 million for fiscal 2017 (the year ended Dec 31, 2017), against -€69.5 million the year before. Source: the 20-F/A filed with the SEC on Apr 5, 2018. SEC
- What are Ablynx NV's total assets?
- As of Dec 31, 2017, Ablynx NV reported total assets of €389.8 million, against €266.8 million a year earlier (+46.1%). Source: the 20-F/A filed with the SEC on Apr 5, 2018. SEC
- What are Ablynx NV's total liabilities?
- As of Dec 31, 2017, Ablynx NV reported total liabilities of €210 million, against €163.7 million a year earlier (+28.3%). Source: the 20-F/A filed with the SEC on Apr 5, 2018. SEC
- What are Ablynx NV's cash and cash equivalents?
- As of Dec 31, 2017, Ablynx NV reported cash and cash equivalents of €15 million, against €53.4 million a year earlier (-72%). Source: the 20-F/A filed with the SEC on Apr 5, 2018. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1617582&period_type=annual&limit=5"Information only, not investment advice.